Edward A Fisher

发表

Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy.

Zahi A Fayad, Valentin Fuster, V. Fuster, 2002, Atherosclerosis.

The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

Zahi A Fayad, David P Cormode, Willem J M Mulder, 2011, Biomaterials.

High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Bernd Hewing, Stanley L Hazen, S. Hazen, 2012, Arteriosclerosis, thrombosis, and vascular biology.

The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects*♦

Stanley L Hazen, Patricia Parsons-Wingerter, S. Hazen, 2013, The Journal of Biological Chemistry.

Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.

Zahi A Fayad, Yanqing Ma, Z. Fayad, 2006, Nano letters.

Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes

Zahi A Fayad, Fabien Hyafil, Venkatesh Mani, 2007, Journal of magnetic resonance imaging : JMRI.

Inflammation and its Resolution as Determinants of Acute Coronary Syndromes

Ira Tabas, Peter Libby, P. Libby, 2014, Circulation research.

Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.

Robin P Choudhury, E. Fisher, R. Choudhury, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

E. Fisher, J. Breslow, K. Maxwell, 2005, Proceedings of the National Academy of Sciences of the United States of America.

High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

Zahi A Fayad, Erling Falk, David P Cormode, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Guidelines for the use and interpretation of assays for monitoring autophagy

Robert Clarke, Hong Jiang, Hiroyuki Ishida, 2012 .

Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Zahi A Fayad, Z. Fayad, E. Fisher, 2004, Journal of the American Chemical Society.

Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI

Zahi A Fayad, Fabien Hyafil, Michael J Lipinski, 2007, Proceedings of the National Academy of Sciences.

Connexin40 Imparts Conduction Heterogeneity to Atrial Tissue

Nicholas S Peters, Carolina Vasquez, D. Leaf, 2008, Circulation research.

Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Axel Thran, Hans C Gerritsen, Heiner Daerr, 2013, ACS nano.

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.

Zhiping Wu, Valentin Gogonea, Stanley L Hazen, 2013, The Journal of clinical investigation.

High-Density Lipoprotein and Atherosclerosis Regression: Evidence From Preclinical and Clinical Studies

Bernd Hewing, Stanley L Hazen, S. Hazen, 2014, Circulation research.

Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1

Axel Thran, Ewald Roessl, Roland Proksa, 2010 .

Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography

Zahi A Fayad, Fabien Hyafil, Jean-Christophe Cornily, 2007, Nature Medicine.

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Aaron N. Chang, Aaron N Chang, K. Moore, 2011, The Journal of clinical investigation.